Abstract
Background: Anaplastic lymphoma kinase (ALK) rearrangement is one of the most important drivers in non-small cell lung cancer (NSCLC). Despite the eff......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
